KERRY-ANN DUDLEY: Open Payments
NPI 1912424359 · BRISTOL, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$696 in 13 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $1,055 · 2025 $696
Food & beverage: $696
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 3 | $265 |
| Mallinckrodt Hospital Products Inc. | 2 | $168 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $104 |
| Abbott Laboratories | 4 | $91 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $25 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
Products named: ULTOMIRIS, TERLIVAZ, JARDIANCE, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, CARDIOMEMS, CAMZYOS, XIFAXAN, NUZYRA.
Industry payments across CT — which companies pay providers there.
